Sign In
Buy MASI
$179.95
+0 (+0%)
At Close: Jun 23, 2026
How Masimo Beat Expectations in Q2
10:20am, Wednesday, 29'th Jul 2020
The company's noninvasive monitoring devices enjoyed especially strong demand for one overriding reason.
Masimo (MASI) Q2 2020 Earnings Call Transcript
03:31am, Wednesday, 29'th Jul 2020
Joining me today are Chairman and CEO Joe Kiani and Executive Vice President of Finance and Chief Financial Officer Micah Young. This call will contain forward-looking statements, which reflect Ma
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
Masimo (MASI) Surpasses Q2 Earnings and Revenue Estimates
11:05pm, Tuesday, 28'th Jul 2020
Masimo (MASI) delivered earnings and revenue surprises of 8.97% and 4.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Masimo's (MASI) CEO Joe Kiani on Q2 2020 Results - Earnings Call Transcript SA Transcripts
09:44pm, Tuesday, 28'th Jul 2020
Masimo Corporation (NASDAQ:MASI) Q2 2020 Earnings Conference Call July 28, 2020 4:30 PM Company Participants Eli Kammerman – Vice President-Business Development and Investor Relations Joe Kiani –
Dexcom Stock Up, Masimo Stock Slips On Medtech Earnings Beats
08:55pm, Tuesday, 28'th Jul 2020
Medtech companies Masimo and Dexcom late Tuesday reported second-quarter earnings that beat expectations, but only Dexcom stock rose as Masimo declined to provide guidance for the year.
Masimo: Q2 Earnings Insights
08:43pm, Tuesday, 28'th Jul 2020
Shares of Masimo (NASDAQ:MASI) decreased 2.25% in after-market trading after the company reported Q2 results.Quarterly Results Earnings per share increased 11.84% year over year to $0.85, which beat t
Masimo Reports Second Quarter 2020 Financial Results
08:05pm, Tuesday, 28'th Jul 2020
Masimo (Nasdaq: MASI) today announced its financial results for the second quarter ended June 27, 2020.
Ensemble Capital Webinar Transcript: Masimo Corp Update | Intrinsic Investing
01:00pm, Tuesday, 28'th Jul 2020
We recently hosted our quarterly client webinar. You can watch the reply HERE and read a full transcript HERE. Below […]
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 27)
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT)
Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO)...
Masimo Expands the Masimo SafetyNet™ Remote Patient Management Solution with Continuous Body Temperature Measurement
12:00pm, Monday, 27'th Jul 2020
Masimo Radius Tº™ adds continuous body temperature measurement to the Masimo SafetyNet™ remote patient management solution.
Masimo Expands the Masimo SafetyNet™ Remote Patient Management Solution with Continuous Body Temperature Measurement
12:00am, Monday, 27'th Jul 2020
Masimo Radius Tº™ adds continuous body temperature measurement to the Masimo SafetyNet™ remote patient management solution.
Ensemble Capitals' Quarterly Investment And Market Update Q2 2020
01:25pm, Friday, 24'th Jul 2020
Ensemble Capital Management, LLC is based in Burlingame, California, midway between Silicon Valley and San Francisco.
Masimo (MASI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
04:31pm, Tuesday, 21'st Jul 2020
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
